174 related articles for article (PubMed ID: 23283449)
21. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
Dasananjali K; Schreuder PA; Pirayavaraporn C
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
[TBL] [Abstract][Full Text] [Related]
22. International open trial of uniform multidrug therapy regimen for leprosy patients: Findings & implications for national leprosy programmes.
Manickam P; Mehendale SM; Nagaraju B; Katoch K; Jamesh A; Kutaiyan R; Jianping S; Mugudalabetta S; Jadhav V; Rajkumar P; Padma J; Kaliaperumal K; Pannikar V; Krishnamurthy P; Gupte MD
Indian J Med Res; 2016 Oct; 144(4):525-535. PubMed ID: 28256460
[TBL] [Abstract][Full Text] [Related]
23. Six years' follow-up of multibacillary leprosy patients treated with uniform multi-drug therapy in China.
Shen J; Yan L; Yu M; Li J; Yu X; Zhang G
Int J Dermatol; 2015 Mar; 54(3):315-8. PubMed ID: 25265933
[TBL] [Abstract][Full Text] [Related]
24. Observations in 11 patients with leprosy and human immunodeficiency virus co-association.
Pai VV; Tayshetye PU; Ganapati R
Indian J Dermatol Venereol Leprol; 2011; 77(6):714-6. PubMed ID: 22016284
[No Abstract] [Full Text] [Related]
25. Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines.
Maghanoy A; Mallari I; Balagon M; Saunderson P
Lepr Rev; 2011 Mar; 82(1):65-9. PubMed ID: 21644473
[TBL] [Abstract][Full Text] [Related]
26. Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia.
Guerrero-Guerrero MI; Muvdi-Arenas S; León-Franco CI
Lepr Rev; 2012 Sep; 83(3):247-60. PubMed ID: 23356026
[TBL] [Abstract][Full Text] [Related]
27. Preliminary assessment of multidrug therapy in leprosy patients in Western Samoa.
Paksoy N; Levi V
N Z Med J; 1989 Nov; 102(879):589-91. PubMed ID: 2812597
[TBL] [Abstract][Full Text] [Related]
28. Leprosy among children under 15 years of age: literature review.
Oliveira MB; Diniz LM
An Bras Dermatol; 2016 Apr; 91(2):196-203. PubMed ID: 27192519
[TBL] [Abstract][Full Text] [Related]
29. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
[TBL] [Abstract][Full Text] [Related]
30. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
Chen XS; Li WZ; Jiang C; Ye GY
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
32. Outcome of 6 months MBMDT in MB patients in Bangladesh- preliminary results.
Butlin CR; Pahan D; Maug AKJ; Withington S; Nicholls P; Alam K; Salim MDAH
Lepr Rev; 2016 Jun; 87(2):171-82. PubMed ID: 30212043
[TBL] [Abstract][Full Text] [Related]
33. Progression of leprosy disability after discharge: is multidrug therapy enough?
Sales AM; Campos DP; Hacker MA; da Costa Nery JA; Düppre NC; Rangel E; Sarno EN; Penna MLF
Trop Med Int Health; 2013 Sep; 18(9):1145-1153. PubMed ID: 23937704
[TBL] [Abstract][Full Text] [Related]
34. Results from the clinical trial of uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): decrease in bacteriological index.
Penna ML; Bűhrer-Sékula S; Pontes MA; Cruz R; Gonçalves Hde S; Penna GO
Lepr Rev; 2014 Dec; 85(4):262-6. PubMed ID: 25675650
[TBL] [Abstract][Full Text] [Related]
35. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
[TBL] [Abstract][Full Text] [Related]
36. Relapses in paucibacillary leprosy after MDT--a clinical study.
Grugni A; Nadkarni NJ; Kini MS; Mehta VR
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
[TBL] [Abstract][Full Text] [Related]
37. Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial.
Dos Santos DS; Duppre NC; Sarno EN; Pinheiro RO; Sales AM; Nery JADC; Moraes MO; Camacho LAB
Trials; 2018 Apr; 19(1):244. PubMed ID: 29685164
[TBL] [Abstract][Full Text] [Related]
38. Comparison between lymecycline with multidrug therapy and standard multidrug regimen (WHO-MDT) in the treatment of multibacillary leprosy patients: a retrospective cohort study.
Diaz JCD; Abad-Venida ML; Espinoza-Thaebtharm A; Cathryn Salonga ME; Abad-Casintahan MF
Int J Dermatol; 2023 Sep; 62(9):1186-1192. PubMed ID: 37408116
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
Manickam P; Nagaraju B; Selvaraj V; Balasubramanyam S; Mahalingam VN; Mehendale SM; Pannikar VK; Gupte MD;
Indian J Lepr; 2012; 84(3):195-207. PubMed ID: 23484334
[TBL] [Abstract][Full Text] [Related]
40. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB
Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]